IL2 and stroke disorder: Previous research has showed that IL-2/IL-2Ab treatment selectively increases the amount of Tregs in the lymph nodes, spleen, and blood, significantly reduces the infarct volume, inhibits neuroinflammation, and improves sensorimotor function compared to stroke mice treated with isotype IgG (27).